HIV-positive TB patients on ART (antiretroviral therapy) in Türkiye
Türkiye: HIV-positive TB patients on ART (antiretroviral therapy) was 85.0% in 2024. ▬ Flat
Latest (2024)
85.0%
Change on year
up 26.9%
World rank
106th
of 144 countries
All-time high
93.0%
in 2011
All-time low
62.0%
in 2013
Years of data
15
2010–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Türkiye, 2010–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hiv-positive tb patients on art (antiretroviral therapy) in Türkiye is 85.0%, measured in 2024.
That represents a change of up 26.9% on the previous year and up 37.1% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Türkiye peaked at 93.0% in 2011 and was at its lowest, 62.0%, in 2013.
Türkiye ranks 106th of 144 countries on this measure, in the middle of the range.
HIV-positive TB patients on ART (antiretroviral therapy) in Türkiye, year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 64.0% | — |
| 2011 | 93.0% | +45.3% |
| 2012 | 78.0% | -16.1% |
| 2013 | 62.0% | -20.5% |
| 2014 | 62.0% | +0.0% |
| 2015 | 92.0% | +48.4% |
| 2016 | 91.0% | -1.1% |
| 2017 | 78.0% | -14.3% |
| 2018 | 78.0% | +0.0% |
| 2019 | 81.0% | +3.8% |
| 2020 | 75.0% | -7.4% |
| 2021 | 75.0% | +0.0% |
| 2022 | 82.0% | +9.3% |
| 2023 | 67.0% | -18.3% |
| 2024 | 85.0% | +26.9% |
Türkiye compared with similar countries
- Türkiye's 85.0% is below the median for upper middle income countries, which is 93.0%, 91% of the median. (48 countries reporting)
- Türkiye's 85.0% is below the median for Europe & Central Asia, which is 96.5%, 88% of the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 77.9% | 62.0% | 93.0% | 10 |
| 2020s | 76.8% | 67.0% | 85.0% | 5 |
Countries ranked near Türkiye
More health data for Türkiye
- Un projection of annual infant deaths, annual growth rate -1.72 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5275 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,582 deaths per 1,000 people (2090)
- Number of infants who die before age 1 858 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0298 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.94 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Türkiye?
- Hiv-positive tb patients on art (antiretroviral therapy) in Türkiye was 85.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Türkiye?
- The highest recorded value was 93.0% in 2011.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Türkiye?
- The lowest recorded value was 62.0% in 2013.
- How does Türkiye rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Türkiye ranks 106th out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Türkiye?
- Over the last ten years it is up 37.1%. The long-run trend across the full record is flat.
- Where does this Türkiye data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).